These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6863926)

  • 21. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-KCA-3, a monoclonal antibody reactive with a rat complement C3 receptor, distinguishes Kupffer cells from other macrophages.
    Maruiwa M; Mizoguchi A; Russell GJ; Narula N; Stronska M; Mizoguchi E; Rabb H; Arnaout MA; Bhan AK
    J Immunol; 1993 May; 150(9):4019-30. PubMed ID: 8473747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of murine natural killer cells and macrophages by 8-bromoguanosine.
    Koo GC; Jewell ME; Manyak CL; Sigal NH; Wicker LS
    J Immunol; 1988 May; 140(9):3249-52. PubMed ID: 2452203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of a delayed type hypersensitivity reaction on the cytotoxic activity of macrophages, natural and antibody-dependent killer cells].
    Gordienko SM
    Eksp Onkol; 1987; 9(1):30-4. PubMed ID: 3816657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic heterogeneity of rat macrophages. A monoclonal antibody reacting only with alveolar but not with other types of macrophages.
    Rumpold H; Förster O; Böck G; Swetly P; Riedl M
    Immunology; 1982 Apr; 45(4):637-43. PubMed ID: 6978283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.
    Ho MK; Springer TA
    J Immunol; 1982 Mar; 128(3):1221-8. PubMed ID: 6173426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO; Johnson WJ; Marino PA; Dean JH
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates.
    Gil J; Alvarez R; Viñuela JE; Ruiz de Morales JG; Bustos A; De la Concha EG; Subiza JL
    Cancer Res; 1990 Nov; 50(22):7301-6. PubMed ID: 2224860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
    Bourassa B; Monaghan S; Rittling SR
    Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-mediated killing of human tumor cells by attached effector cells.
    Hellström I; Garrigues U; Lavie E; Hellström KE
    Cancer Res; 1988 Feb; 48(3):624-7. PubMed ID: 3335025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
    Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
    Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel rat monoclonal antibody directed against a population of activated mouse peritoneal macrophages.
    Someya A
    Microbiol Immunol; 1986; 30(6):573-88. PubMed ID: 3747866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.
    Langlois AJ; Matthews T; Roloson GJ; Thiel HJ; Collins JJ; Bolognesi DP
    J Immunol; 1981 Jun; 126(6):2337-41. PubMed ID: 7229378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
    Lefebvre ML; Krause SW; Salcedo M; Nardin A
    J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
    No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of monoclonal antibodies that define rat T cell alloantigens.
    Ely JM; Greiner DL; Lubaroff DM; Fitch FW
    J Immunol; 1983 Jun; 130(6):2798-803. PubMed ID: 6343484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.